At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
Citicoline, Omega-3 Fatty Acids and Creatinedrug
Likely dose
Citicoline, Omega-3 Fatty Acids and Creatine 500 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Citicoline, Creatine, and Omega-3 Effects in Middle Age Women
In Brief
A clinical study evaluating Citicoline, Omega-3 Fatty Acids and Creatine for Cognitive Benefits. Completed, enrolled 40 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the functional effects of a citicoline, creatine, and omega-3 fatty acids combination when administered for a duration of four weeks (28 days) to non-psychiatric adult female participants.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCognitive Benefits
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJan 2012
Enrollment StartFeb 2012
Primary CompletionOct 2018
Study CompletionNov 2019
TodayJul 2026
First PostedJan 2, 2012
Enrollment StartFeb 1, 2012
Primary CompletionOct 30, 2018
Study CompletionNov 1, 2019
TodayJul 2, 2026
Enrollment to primary: 6.7 yearsPosted 14.5 years ago
Interventions
Citicoline, Omega-3 Fatty Acids and Creatinedrug
Citicoline: 500 mg/day for 28 days Omega-3 Fatty Acids: 2 g/day for 28 days Creatine: 5 g/day for 28 days